Biotinylated Human HLA-A*02:01&B2M&Glypican 3 (FVGEFFTDV) Complex Protein (Monomer, MALS verified) [HLG-H82E4]

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー: AcroBioSystems
カタログNo.: HLG-H82E4
製品名称: Biotinylated Human HLA-A*02:01&B2M&Glypican 3 (FVGEFFTDV) Complex Protein (Monomer, MALS verified)
タンパク質名: HLA-A*02:01 & B2M & Glypican 3 (FVGEFFTDV)
Species: Human
HOST: HEK293

Synonyms	-
Characteristics	Biotinylated Human HLA-A*02:01&B2M&Glypican 3 (FVGEFFTDV) Complex Protein is produced by co-expression of HLA and B2M loaded with Glypican 3 peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?). The protein has a calculated MW of 36.0 kDa and 13.8 kDa. The protein migrates as 42-45 kDa and 14 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level	N/A
Purity	95%
Description	Glypican-3 (GPC3) is also known as Intestinal protein OCI-5, GTR2-2, MXR7, which belongs to the glypican family. Glypican 3 / GPC-3 is highly expressed in lung, liver and kidney. Glypican-3 inhibits the dipeptidyl peptidase activity of DPP4. Glypican-3 may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and also may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. The Human HLA-A0201 Glycipan 3 (FVGEFFTDV) complex protein is a complex of HLA-A0201 of?the MHC Class I, B2M and FVGEFFTDV peptide of?the Glycipan 3 .
Reference	-
URL	https://www.acrobiosystems.com/products/protein/hla-a-02:01-b2m-glypican-3-fvgefftdv-human-hlg-h82e4

バイオ製品Bio Products